How Analyst Resets Are Reshaping The Exagen (XGN) Investment Story [Yahoo! Finance]
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Analysts have been trimming their price targets on Exagen, with recent updates clustering in the US$9 to US$10 range, while a fair value anchor of US$9.50 remains unchanged. These revisions are tied to softer pricing assumptions, more measured revenue curves, and a slower expected build in gross margins. At the same time, they still point to volume trends and long term earnings potential as key positives. As you read on, you will see how these moving pieces shape the evolving Exagen story and what to watch in the next round of updates. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Exagen. What Wall Street Has Been Saying ?? Bullish Takeaways Craig Hallum, Canaccord, KeyBanc, BTIG, TD Cowen, and B. Riley all maintain positive ratings even after trimming targets, which signals continued interest in Exagen's long term earnings potential. Several firms, including Craig Hallum and TD Cowen, point to healthy t
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- Exagen (XGN) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=XGN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "sell".MarketBeat
- Exagen (XGN) had its price target lowered by Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen (XGN) had its price target lowered by Craig Hallum from $12.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen (XGN) had its price target lowered by KeyCorp from $15.00 to $10.00. They now have an "overweight" rating on the stock.MarketBeat
- Avolta AG GAAP EPS of CHF 1.36, revenue of CHF 13.76B [Seeking Alpha]Seeking Alpha
XGN
Earnings
- 3/10/26 - In-Line
XGN
Sec Filings
- 3/16/26 - Form 3
- 3/16/26 - Form 4
- 3/16/26 - Form 4
- XGN's page on the SEC website